Latest Breaking News On - Benoit woessmer - Page 1 : comparemela.com

Curium Announces First Commercial Doses in France of Pylclari® - an Innovative 18F-Psma Pet Tracer Indicated in Patients With Prostate Cancer

PARIS, May 30, 2024 (GLOBE NEWSWIRE) Curium, a world leader in nuclear medicine, today announced that earlier this month patients in France received the first doses of PYLCLARI® (INN: Piflufolastat

France generalUnited statesRoss bethellPierre curieBenoit woessmerHead of global communicationsDrug administrationIhr portfolio

Curium Announces First Commercial Doses in France of

first doses of PYLCLARI in France for prostate cancer patients.

United statesFrance generalBenoit woessmerRoss bethellPierre curieHead of global communicationsDrug administration

Curium Announces First Commercial Dose in the Netherlands

Curium proudly introduces the first commercial dose of PYLCLARI® in the Netherlands, revolutionizing prostate cancer diagnosis. This innovative 18F-PSMA.

France generalUnited statesNoord hollandBenoit woessmerPierre curieRoss bethellDrug administrationEuropean unionEuropean commissionHead of global communicationsCurium us llcSma pet tracerProstate cancer

Curium Announces First Commercial Dose in the Netherlands of PYLCLARI® - an Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer

Curium Announces First Commercial Dose in the Netherlands of PYLCLARI® - an Innovative 18F-PSMA PET Tracer Indicated in Patients With Prostate Cancer
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesNoord hollandFrance generalBenoit woessmerPierre curieRoss bethellDennis riedlDrug administrationEuropean unionEuropean commissionHead of global communications

Curium Announces Submission of the Marketing Authorization Application for PYLCLARI®, an Innovative (18F)-PSMA PET Tracer Indicated in Adults With Prostate Cancer to Swissmedic

Curium Announces Submission of the Marketing Authorization Application for PYLCLARI®, an Innovative (18F)-PSMA PET Tracer Indicated in Adults With Prostate Cancer to Swissmedic
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

France generalUnited statesMichel wuilleminPierre curieRoss bethellBenoit woessmerHead of global communicationsEuropean commissionSwiss agency for therapeutic products swissmedicDrug administrationSwiss agencyTherapeutic productsMarketing authorization applicationEuropean medicines agency